The Patent Finder

PMV Pharmaceuticals, Inc.

12 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 22, 2027
    The maintenance fee for Methods and compounds for restoring mutant p53 function (US 11,731,953) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
  • 2 fees due May 7 to 14, 2027 · next May 7
  • 2 fees due Sep 12 to 26, 2027 · next Sep 12
  • 1 fee due Oct 23, 2027
    The maintenance fee for DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION (US 11,963,953) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
  • 1 fee due Nov 5, 2027
    The maintenance fee for Methods and Compounds for Restoring Mutant P53 Function (US 10,640,485) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,138,219Methods and compounds for restoring mutant p53 function
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,640,485Methods and Compounds for Restoring Mutant P53 Function
In force
 · Low confidence
In forceLow confidence
US 11,339,141METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
In force
 · Medium confidence
In forceMedium confidence
US 12,419,880Companion Diagnostic Tool for Mutant P53 Reactivating Compounds
In force
 · High confidence
In forceHigh confidence
US 12,428,406METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
In force
 · High confidence
In forceHigh confidence
US 12,570,645Uses of P53 X-Ray Co-Crystal Structures
In force
 · Medium confidence
In forceMedium confidence
US 11,814,373METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
In force
 · High confidence
In forceHigh confidence
US 11,807,644Methods and compounds for restoring mutant p53 function
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,926,632Methods and compounds for restoring mutant p53 function
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,731,953Methods and compounds for restoring mutant p53 function
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited